- Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
- Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
- Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study
- Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
- Structure Therapeutics Announces $300 Million Private Placement Equity Financing
- Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
- Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
- Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
More ▼
Key statistics
On Wednesday, Structure Therapeutics Inc (GPCR:NMQ) closed at 39.32, 80.45% above the 52 week low of 21.79 set on May 18, 2023.
52-week range
Open | 39.40 |
---|---|
High | 40.71 |
Low | 38.75 |
Bid | 15.82 |
Offer | 60.00 |
Previous close | 39.32 |
Average volume | 485.93k |
---|---|
Shares outstanding | 46.60m |
Free float | 35.44m |
P/E (TTM) | -- |
Market cap | 1.83bn USD |
EPS (TTM) | -2.51 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼